Avoro Capital Advisors LLC 13D and 13G filings for Taysha Gene Therapies, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 09:40 am Purchase | 2024-09-30 | 13G | Taysha Gene Therapies, Inc. TSHA | Avoro Capital Advisors LLC | 23,094,444 9.990% | 23,094,444 (New Position) | Filing |